Molecular Genetics & Genomic Medicine

Journal website Submission website

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

MOL GENET GENOM MED

ISSN / eISSN

2324-9269 / 2324-9269

Aims and Scope

Molecular Genetics & Genomic Medicine is a peer-reviewed journal for rapid dissemination of quality research related to the dynamically developing areas of human, molecular and medical genetics. The journal publishes original research articles covering findings in phenotypic, molecular, biological, and genomic aspects of genomic variation, inherited disorders and birth defects. The broad publishing spectrum of Molecular Genetics & Genomic Medicine includes rare and common disorders from diagnosis to treatment. Examples of appropriate articles include reports of novel disease genes, functional studies of genetic variants, in-depth genotype-phenotype studies, genomic analysis of inherited disorders, molecular diagnostic methods, medical bioinformatics, ethical, legal, and social implications (ELSI), and approaches to clinical diagnosis. Molecular Genetics & Genomic Medicine provides a scientific home for next generation sequencing studies of rare and common disorders, which will make research in this fascinating area easily and rapidly accessible to the scientific community. This will serve as the basis for translating next generation sequencing studies into individualized diagnostics and therapeutics, for day-to-day medical care.

Molecular Genetics & Genomic Medicine publishes original research articles, reviews, and research methods papers, along with invited editorials and commentaries. Original research papers must report well-conducted research with conclusions supported by the data presented.

Subject Area

GENETICS & HEREDITY

CiteScore

4.40

View Trend

CiteScore Ranking

Category	Quartile	Rank
Biochemistry, Genetics and Molecular Biology - Genetics	Q3	#183/328
Biochemistry, Genetics and Molecular Biology - Genetics (clinical)	Q3	#53/90
Biochemistry, Genetics and Molecular Biology - Molecular Biology	Q3	#262/380

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
GENETICS & HEREDITY - SCIE	Q3

H-index

Country/Area of Publication

United States

Publisher

John Wiley and Sons Inc.

Annual Article Volume

239

Open Access

YES

Contact

111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Popular journals in the same field
Recent articles

Identification of a novel LMX1B nonsense variant associated with congenital talipes equinovarus by prenatal exome sequencing: A case report: (2023) Jing Chen, Qinqin Xiang, Xiao Xiao, Bocheng Xu, Hanbing Xie, He Wang, Mei Yang, Shanling Liu

Height of non‐Hispanic white adults with homeostatic iron regulator HFE genotypes p.C282Y/p.C282Y and wt/wt: (2023) James C. Barton, J. Clayborn Barton, Ronald T. Acton

Hearing characteristics and otoradiological abnormalities in three patients with novel pathogenic variants of KMT2D‐related Kabuki syndrome: (2023) Zhoushu Zheng, Lu Ding, Meihong Wang, Yinghui Zhang, Yihui Yang, Ming Tang, Jun Xu, Liangjiong Wang, Junhua Wu, Haibo Li

Novel PNKP mutations associated with reduced DNA single‐strand break repair and severe microcephaly, seizures, and developmental delay: (2023) Ann‐Charlotte Thuresson, Jan Brazina, Talia Akram, Julia Albrecht, Niklas Dahl, Cecilia Soussi Zander, Keith W. Caldecott

Case report of a child with long QT syndrome type 14 caused by CALM1 gene mutation and literature review: (2023) Qiqing Sun, Zhenhua Xie, Fangjie Wang, Jun Guo, Xiaochen Yan

A further case of AFG2B‐related neurodevelopmental disorder with hearing loss and microcephaly allows further clarification of pathogenicity of the variant c.1313T>C, p.(Leu438Pro): (2023) Sarah Grosch, Martin Kehrer, Olaf Riess, Andrea Bevot, Tobias B. Haack

Optical genome mapping reveals balanced and unbalanced genetic changes associated with tumor‐forming potential in an early‐stage prostate cancer epithelial subline (M2205): (2023) Prabakaran Paulraj, Elizabeth Barrie, Colleen Jackson‐Cook

Novel compound heterozygous mutations in OCA2 gene were identified in a Chinese family with oculocutaneous albinism: (2023) Beilei Jiang, Hua Zhang, Yuling Kan, Xueping Gao, Zhaoli Du, Quan Liu

COPA syndrome caused by a novel p.Arg227Cys COPA gene variant: (2023) Yue Zheng, Yue Du, Yubin Wu, Fuwei Li, Weiyue Gu, Chengguang Zhao

A novel de novo frameshift variant in the CHD2 gene related to intellectual and developmental disability, seizures and speech problems: (2023) Atefeh Mir, Yongjun Song, Hane Lee, Zakiye Nadeali, Mohammad Amin Tabatabaiefar

Verified Reviews

Note: Verified reviews are sourced from across review platforms and social media globally.

The review speed is very happy. It took one and a half months for the first review. My submission was a case, and the reviewer was particularly serious and responsible. It went through six revisions, and the total duration from the initial submission to acceptance took nine months. However, the reviewer was very meticulous, and both the review speed and the revision speed were fast. The revision process also took a long time, about two months. This is a new journal, and it feels like there is potential for future growth. They consider cases as articles in their journal.

2021-03-05

View All Reviews

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started